Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-06-09
著者
-
Gillespie Todd
Lilly Research Laboratories Eli Lilly And Company Lilly Corporate Center
-
Gillespie Todd
Lilly Research Laboratories Department Of Drug Metabolism And Disposition
-
Swanson Steven
Lilly Research Laboratories Eli Lilly And Company Lilly Corporate Center
-
Swanson Steven
Lilly Research Laboratories Department Of Drug Metabolism And Disposition
-
Goodwin Michael
Lilly Research Laboratories Department Of Drug Metabolism And Disposition
-
CATLOW John
Lilly Research Laboratories, Department of Drug Metabolism and Disposition
-
BARTON Richard
Lilly Research Laboratories, Department of Drug Metabolism and Disposition
-
CLEMENS Matt
Lilly Research Laboratories, Department of Drug Metabolism and Disposition
-
Catlow John
Lilly Research Laboratories Department Of Drug Metabolism And Disposition
-
Clemens Matt
Lilly Research Laboratories Department Of Drug Metabolism And Disposition
-
Barton Richard
Lilly Research Laboratories Department Of Drug Metabolism And Disposition
関連論文
- Determination of a novel α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor antagonist (LY300164) and its N-acetyl metabolite in mouse, rat, dog, and monkey plasma using high-performance liquid chromatography with ultraviolet detection
- Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection
- Determination of the muscarinic agent [(3-(3-1-butylthio)-1,2,5-thiadiazol-4-yl)-1-azabicyclo[2.2.2]octane], in rat, rabbit, and monkey plasma, using high-performance liquid chromatography in conjunction with tandem mass spectrometry